203 related articles for article (PubMed ID: 20412876)
1. Persistence of mucosal and systemic immune responses following sublingual immunization.
Negri DR; Riccomi A; Pinto D; Vendetti S; Rossi A; Cicconi R; Ruggiero P; Del Giudice G; De Magistris MT
Vaccine; 2010 Jun; 28(25):4175-80. PubMed ID: 20412876
[TBL] [Abstract][Full Text] [Related]
2. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.
Amuguni JH; Lee S; Kerstein KO; Brown DW; Belitsky BR; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
Vaccine; 2011 Jun; 29(29-30):4778-84. PubMed ID: 21565244
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
[TBL] [Abstract][Full Text] [Related]
4. Transcutaneous immunization with tetanus toxoid and mutants of Escherichia coli heat-labile enterotoxin as adjuvants elicits strong protective antibody responses.
Tierney R; Beignon AS; Rappuoli R; Muller S; Sesardic D; Partidos CD
J Infect Dis; 2003 Sep; 188(5):753-8. PubMed ID: 12934192
[TBL] [Abstract][Full Text] [Related]
5. Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.
Sjökvist Ottsjö L; Jeverstam F; Yrlid L; Wenzel AU; Walduck AK; Raghavan S
Immunology; 2017 Feb; 150(2):172-183. PubMed ID: 27676456
[TBL] [Abstract][Full Text] [Related]
6. The immune response of two microbial antigens delivered intradermally, sublingually, or the combination thereof.
Lee S; Picking WL; Tzipori S
Microbes Infect; 2014 Sep; 16(9):796-803. PubMed ID: 25111827
[TBL] [Abstract][Full Text] [Related]
7. The acquired immune response to the mucosal adjuvant LTK63 imprints the mouse lung with a protective signature.
Tritto E; Muzzi A; Pesce I; Monaci E; Nuti S; Galli G; Wack A; Rappuoli R; Hussell T; De Gregorio E
J Immunol; 2007 Oct; 179(8):5346-57. PubMed ID: 17911621
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.
Takahashi I; Marinaro M; Kiyono H; Jackson RJ; Nakagawa I; Fujihashi K; Hamada S; Clements JD; Bost KL; McGhee JR
J Infect Dis; 1996 Mar; 173(3):627-35. PubMed ID: 8627026
[TBL] [Abstract][Full Text] [Related]
9. TLR2-dependent modulation of dendritic cells by LT-IIa-B5, a novel mucosal adjuvant derived from a type II heat-labile enterotoxin.
Lee CH; Masso-Welch P; Hajishengallis G; Connell TD
J Leukoc Biol; 2011 Nov; 90(5):911-21. PubMed ID: 21791597
[TBL] [Abstract][Full Text] [Related]
10. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
Ryan EJ; McNeela E; Murphy GA; Stewart H; O'hagan D; Pizza M; Rappuoli R; Mills KH
Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the LTK63 adjuvant effect on cellular immune responses to measles virus nucleoprotein.
Erume J; Partidos CD
Afr Health Sci; 2011 Jun; 11(2):151-7. PubMed ID: 21857843
[TBL] [Abstract][Full Text] [Related]
12. Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities.
Nawar HF; Arce S; Russell MW; Connell TD
Infect Immun; 2005 Mar; 73(3):1330-42. PubMed ID: 15731030
[TBL] [Abstract][Full Text] [Related]
13. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant.
Di Tommaso A; Saletti G; Pizza M; Rappuoli R; Dougan G; Abrignani S; Douce G; De Magistris MT
Infect Immun; 1996 Mar; 64(3):974-9. PubMed ID: 8641809
[TBL] [Abstract][Full Text] [Related]
14. Mucosal vaccination shapes the expression of salivary antibodies and establishment of CD8+ T-cells.
Polak D; Benzki-Namdar E; Houri-Haddad Y; Shapira L
J Periodontol; 2014 Jul; 85(7):991-7. PubMed ID: 24359165
[TBL] [Abstract][Full Text] [Related]
15. Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge.
Beignon AS; Briand JP; Muller S; Partidos CD
Immunology; 2001 Mar; 102(3):344-51. PubMed ID: 11298834
[TBL] [Abstract][Full Text] [Related]
16. GM1 binding-deficient exotoxin is a potent noninflammatory broad spectrum intradermal immunoadjuvant.
Zoeteweij JP; Epperson DE; Porter JD; Zhang CX; Frolova OY; Constantinides AP; Fuhrmann SR; El-Amine M; Tian JH; Ellingsworth LR; Glenn GM
J Immunol; 2006 Jul; 177(2):1197-207. PubMed ID: 16818778
[TBL] [Abstract][Full Text] [Related]
17. Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants.
McCluskie MJ; Weeratna RD; Clements JD; Davis HL
Vaccine; 2001 Jun; 19(27):3759-68. PubMed ID: 11395211
[TBL] [Abstract][Full Text] [Related]
18. Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses.
Simmons CP; Hussell T; Sparer T; Walzl G; Openshaw P; Dougan G
J Immunol; 2001 Jan; 166(2):1106-13. PubMed ID: 11145691
[TBL] [Abstract][Full Text] [Related]
19. Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen.
Hu JC; Mathias-Santos C; Greene CJ; King-Lyons ND; Rodrigues JF; Hajishengallis G; Ferreira LC; Connell TD
PLoS One; 2014; 9(12):e113978. PubMed ID: 25536061
[TBL] [Abstract][Full Text] [Related]
20. Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice.
Jakobsen H; Bjarnarson S; Del Giudice G; Moreau M; Siegrist CA; Jonsdottir I
Infect Immun; 2002 Mar; 70(3):1443-52. PubMed ID: 11854231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
